0,956  0,002  Antihypercholesterolemic
0,953  0,001  Cholesterol antagonist
0,946  0,001  UGT1A4 substrate
0,921  0,003  CYP2C19 substrate
0,919  0,002  NOS3 expression inhibitor
0,903  0,004  Teratogen
0,897  0,004  Embryotoxic
0,881  0,005  CYP3A4 substrate
0,875  0,005  TNF expression inhibitor
0,872  0,002  UGT2B1 substrate
0,857  0,001  Antihyperlipoproteinemic
0,859  0,004  Respiratory analeptic
0,857  0,004  Chemopreventive
0,849  0,002  Sulfotransferase substrate
0,851  0,005  Carcinogenic
0,850  0,009  Antiinflammatory
0,836  0,005  Chemoprotective
0,830  0,002  Hair growth stimulant
0,824  0,004  CTGF expression inhibitor
0,824  0,004  Bone diseases treatment
0,819  0,003  Anesthetic
0,803  0,002  Androgen antagonist
0,799  0,003  Proliferative diseases treatment
0,796  0,000  Cholesterol synthesis inhibitor
0,809  0,016  Apoptosis agonist
0,796  0,005  Antiosteoporotic
0,786  0,001  UGT2B7 substrate
0,788  0,004  Hepatic disorders treatment
0,784  0,003  Anesthetic general
0,773  0,001  UGT2B4 substrate
0,763  0,002  Anticataract
0,775  0,014  Caspase 9 stimulant
0,760  0,002  Pregnane X receptor agonist
0,758  0,005  Lipoprotein disorders treatment
0,756  0,005  Antiepileptic
0,757  0,009  CYP2C9 substrate
0,749  0,006  Analeptic
0,741  0,004  UDP-glucuronosyltransferase substrate
0,739  0,003  Amylase inhibitor
0,737  0,004  UGT1A1 substrate
0,749  0,016  Transcription factor NF kappa B inhibitor
0,732  0,007  Sensitization
0,728  0,003  Prostatic (benign) hyperplasia treatment
0,725  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,727  0,005  UGT1A6 substrate
0,712  0,002  Autism spectrum disorders treatment
0,709  0,004  Amyotrophic lateral sclerosis treatment
0,704  0,003  Antipruritic, allergic
0,701  0,005  Antipsoriatic
0,660  0,003  Retinoprotector
0,647  0,010  Atherosclerosis treatment
0,634  0,001  Liver X receptor alpha agonist
0,632  0,004  Hedgehog signaling inhibitor
0,630  0,004  UGT1A3 substrate
0,628  0,007  Apoptosis antagonist
0,615  0,005  Sedative
0,612  0,006  Hypolipemic
0,608  0,007  Metabolic disease treatment
0,604  0,004  Phospholipase C inhibitor
0,605  0,012  Immunosuppressant
0,617  0,025  Cyclophilin D inhibitor
0,617  0,025  Antidiabetic
0,605  0,018  Prostate cancer treatment
0,597  0,012  Cytotoxic
0,585  0,002  Farnesoid X receptor antagonist
0,583  0,001  5-Alpha-reductase 2 inhibitor
0,576  0,002  Sodium/bile acid cotransporter inhibitor
0,571  0,003  Interferon gamma antagonist
0,580  0,013  Inflammatory Bowel disease treatment
0,570  0,004  Antiacne
0,566  0,001  5-Alpha-reductase inhibitor
0,565  0,003  Abortion inducer
0,573  0,012  NOS2 expression inhibitor
0,556  0,001  5-Alpha-reductase 1 inhibitor
0,566  0,015  Immunomodulator
0,550  0,005  Interleukin 2 agonist
0,546  0,003  Prostate disorders treatment
0,542  0,003  Antiinfertility, female
0,540  0,004  Contraceptive
0,537  0,002  UGT2B9 substrate
0,534  0,007  Interleukin agonist
0,526  0,007  Antineoplastic (liver cancer)
0,514  0,004  Lipocortins synthesis antagonist
0,512  0,002  Antipruritic, non-allergic
0,533  0,025  Immunostimulant
0,531  0,023  Antineoplastic (ovarian cancer)
0,550  0,044  Antineoplastic (breast cancer)
0,513  0,006  Hepatoprotectant
0,510  0,005  Antiparkinsonian, rigidity relieving
0,522  0,018  Antifungal
0,507  0,004  DNA polymerase I inhibitor
0,498  0,002  Bile acid receptor antagonist
0,513  0,020  Antineoplastic (pancreatic cancer)
0,497  0,012  Renal disease treatment
0,491  0,008  Muscle relaxant
0,483  0,005  Liver fibrosis treatment
0,499  0,021  AR expression inhibitor
0,485  0,008  Diuretic
0,490  0,017  Nitric oxide antagonist
0,470  0,002  Androgen agonist
0,490  0,027  CYP2D6 substrate
0,450  0,003  Contraceptive female
0,468  0,045  Antiobesity
0,426  0,005  Psychosexual dysfunction treatment
0,422  0,002  Actinic keratosis treatment
0,451  0,031  Antineoplastic (melanoma)
0,421  0,003  Choleretic
0,438  0,022  Hypoxia-inducible factor 1 alpha inhibitor
0,416  0,001  Glycine receptor agonist
0,436  0,029  Antioxidant
0,436  0,031  Radioprotector
0,410  0,005  Liver cirrhosis treatment
0,431  0,029  UGT1A9 substrate
0,427  0,030  ICAM1 expression inhibitor
0,400  0,008  UGT2B15 substrate
0,438  0,053  Antileukemic
0,438  0,061  Antibacterial
0,399  0,024  Antineoplastic (renal cancer)
0,378  0,004  LDLR expression enhancer
0,377  0,004  ABCA1 expression enhancer
0,394  0,027  Cardiodepressant
0,375  0,009  Antiviral (Influenza A)
0,378  0,014  Diabetic retinopathy treatment
0,371  0,010  Protein kinase stimulant
0,395  0,037  Antineoplastic (glioma)
0,402  0,044  Caspase 3 stimulant
0,369  0,015  Antiviral (Influenza)
0,352  0,000  Hedgehog signaling activator
0,371  0,033  Hypoglycemic
0,342  0,005  Antineoplastic, alkylator
0,339  0,003  CDC25A inhibitor
0,353  0,019  Antiviral (Herpes)
0,342  0,008  Endometrios treatment
0,338  0,004  Alcohol dehydrogenase substrate
0,364  0,031  Myocardial infarction treatment
0,341  0,009  Growth factor agonist
0,376  0,049  Antihypertensive
0,357  0,031  Angiogenesis stimulant
0,323  0,002  Anticholelithogenic
0,360  0,041  Antidiabetic (type 2)
0,357  0,040  Cytostatic
0,317  0,002  RNA-directed RNA polymerase stimulant
0,384  0,069  Antineoplastic (lung cancer)
0,316  0,004  UGT2B10 substrate
0,360  0,049  Antineoplastic (brain cancer)
0,344  0,036  Antineoplastic (endocrine cancer)
0,321  0,019  Antialcoholic
0,340  0,038  Antineoplastic (glioblastoma multiforme)
0,297  0,002  Arachidonic acid antagonist
0,301  0,006  Contraceptive male
0,297  0,003  Hyperparathyroidism treatment
0,334  0,045  Antipyretic
0,306  0,020  Skeletal muscle relaxant
0,302  0,017  Neurotrophic factor enhancer
0,301  0,018  NOS3 expression enhancer
0,289  0,011  Antifungal enhancer
0,297  0,022  Melanin inhibitor
0,291  0,019  Muscular dystrophy treatment
0,316  0,046  Antidiabetic symptomatic
0,274  0,005  Aromatase inhibitor
0,271  0,004  Liver X receptor agonist
0,319  0,052  Antineoplastic (cervical cancer)
0,279  0,013  Protein-tyrosine phosphatase 1B inhibitor
0,271  0,005  Postmenopausal disorders treatment
0,271  0,005  Estrogen agonist
0,312  0,047  Antineoplastic (lymphoma)
0,265  0,003  Lanosterol 14 alpha demethylase inhibitor
0,318  0,061  CYP1A2 substrate
0,275  0,024  Protein-tyrosine phosphatase inhibitor
0,288  0,038  Wound healing agent
0,299  0,050  Vascular (periferal) disease treatment
0,309  0,060  Antineoplastic (multiple myeloma)
0,258  0,011  Neurotrophic factor
0,249  0,003  Liver X receptor beta agonist
0,248  0,004  Hypercalcemia treatment
0,258  0,019  Antidiabetic (type 1)
0,241  0,003  Glycine receptor antagonist
0,314  0,078  Calcium channel activator
0,240  0,007  AMP-activated protein kinase stimulant
0,275  0,046  Antihypertriglyceridemic
0,274  0,045  EphB2 antagonist
0,252  0,024  Bone formation stimulant
0,269  0,043  Platelet adhesion inhibitor
0,247  0,021  Toxic, respiratory center
0,246  0,021  Antidiarrheal
0,251  0,029  Diabetic nephropathy treatment
0,221  0,003  UGT2B11 substrate
0,216  0,003  Anabolic
0,261  0,049  Antiviral (HIV)
0,237  0,029  Antipruritic
0,247  0,040  Male reproductive disfunction treatment
0,208  0,003  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,263  0,058  Antineoplastic (sarcoma)
0,263  0,063  Free radical scavenger
0,212  0,013  Growth stimulant
0,210  0,012  Estrogen antagonist
0,241  0,044  P-glycoprotein inhibitor
0,225  0,032  Carcinogenic, group 3
0,197  0,005  Estrogen receptor alpha agonist
0,309  0,118  CYP2C19 inhibitor
0,193  0,002  Na+ K+ transporting ATPase inhibitor
0,192  0,001  Cholesterol absorption inhibitor
0,185  0,002  Vitamin D receptor antagonist
0,187  0,005  Paget's disease treatment
0,213  0,033  Neuropathy treatment
0,210  0,033  Skin irritative effect
0,235  0,062  Antineoplastic enhancer
0,177  0,004  Aldosterone antagonist
0,244  0,076  Antiprotozoal (Leishmania)
0,179  0,011  Inducible nitric-oxide synthase inhibitor
0,189  0,022  Microtubule formation inhibitor
0,175  0,010  SULT1E1 substrate
0,169  0,006  Estrogen receptor beta agonist
0,200  0,037  Skin whitener
0,224  0,064  VCAM1 expression inhibitor
0,163  0,005  CDC25B inhibitor
0,163  0,005  Progesterone antagonist
0,313  0,155  Alzheimer's disease treatment
0,161  0,006  Cushing's syndrome treatment
0,178  0,024  SULT1A1 substrate
0,216  0,063  Mutagenic
0,156  0,003  Farnesoid X receptor agonist
0,195  0,044  Lipid peroxidase inhibitor
0,180  0,028  Antihemorrhagic
0,153  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,222  0,073  Antiulcerative
0,159  0,010  Estrogen receptor alpha antagonist
0,245  0,100  Cardioprotectant
0,229  0,086  Tumour necrosis factor alpha release inhibitor
0,162  0,028  Antineoplastic antibiotic
0,265  0,132  Stroke treatment
0,227  0,095  DNA damaging
0,148  0,016  Estrogen receptor beta antagonist
0,162  0,031  Menstruation disorders treatment
0,154  0,026  Antineoplastic alkaloid
0,179  0,055  Interleukin 6 antagonist
0,199  0,080  Psychostimulant
0,122  0,003  Lipocortins synthesis agonist
0,172  0,054  Insulin secretagoues
0,128  0,013  Premenstrual syndrome treatment
0,224  0,114  Gastrin inhibitor
0,228  0,119  Antihypoxic
0,114  0,004  Glucocorticoid antagonist
0,122  0,013  SULT1A2 substrate
0,110  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,141  0,035  HDL-cholesterol increasing
0,206  0,101  Cardiovascular analeptic
0,154  0,050  Antieczematic
0,147  0,048  Alkylator
0,105  0,007  SULT2A1 substrate
0,099  0,001  Vitamin D receptor agonist
0,172  0,074  Antineoplastic (bone cancer)
0,198  0,103  RNA-directed DNA polymerase inhibitor
0,208  0,114  5 Hydroxytryptamine release stimulant
0,097  0,004  Parathyroid hormone antagonist
0,128  0,036  Toll-Like receptor 4 antagonist
0,097  0,007  Postcoital contraceptive
0,189  0,102  Age-related macular degeneration treatment
0,156  0,070  Acute respiratory distress syndrome (ARDS) treatment
0,095  0,008  Mineralocorticoid receptor antagonist
0,139  0,053  Antiviral (Hepatitis B)
0,158  0,073  Eye irritation, high
0,138  0,055  Aldehyde dehydrogenase inhibitor
0,135  0,056  Anesthetic local
0,169  0,090  Antihelmintic
0,117  0,040  Prolactin inhibitor
0,123  0,046  Neutropenia treatment
0,203  0,131  Antineoplastic (colorectal cancer)
0,085  0,014  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,120  0,051  Expectorant
0,072  0,004  HMG CoA reductase inhibitor
0,083  0,016  Andropause treatment
0,092  0,026  HIV-1 integrase (Strand Transfer) inhibitor
0,096  0,031  Estrogen-related receptor beta agonist
0,109  0,044  Posttraumatic stress disorder treatment
0,120  0,055  Glutathione S-transferase substrate
0,066  0,004  CYP24 inhibitor
0,190  0,130  Antineoplastic (colon cancer)
0,063  0,003  Ileal bile acid transport inhibitor
0,066  0,007  Hypogonadism treatment
0,061  0,006  Estrone sulfatase inhibitor
0,097  0,042  Transcription factor NF kappa B stimulant
0,068  0,016  Anesthetic inhalation
0,077  0,027  Interferon inducer
0,072  0,023  Heme oxygenase stimulant
0,052  0,004  Glucocorticoid agonist
0,050  0,005  Progesterone agonist
0,160  0,115  CYP2B6 inhibitor
0,048  0,003  Corticosteroid-like
0,104  0,062  Protease inhibitor
0,049  0,008  Ceramide glucosyltransferase inhibitor
0,107  0,069  Mucolytic
0,082  0,045  Antibiotic
0,178  0,140  Antihypotensive
0,118  0,080  Cyclooxygenase 3 inhibitor
0,111  0,074  Proteasome inhibitor
0,069  0,034  Nitric oxide donor
0,090  0,055  Ornithine decarboxylase inhibitor
0,168  0,133  Antineoplastic (non-small cell lung cancer)
0,082  0,048  Interferon agonist
0,055  0,022  Microtubule stabilization
0,058  0,025  Heparanase inhibitor
0,120  0,088  Vanilloid 1 agonist
0,131  0,099  Adenylate cyclase stimulant
0,036  0,004  Apical sodium codependent bile acid transporter inhibitor
0,156  0,126  Antiparasitic
0,130  0,100  Antifungal (Cryptococcus)
0,197  0,167  Antiallergic
0,077  0,050  Antitreponemal
0,062  0,035  Botulinum neurotoxin type A inhibitor
0,082  0,055  Sleep apnea treatment
0,027  0,001  Transcortin receptor antagonist
0,133  0,107  Aldose reductase substrate
0,162  0,137  VEGF expression inhibitor
0,033  0,009  1,3-Beta-glucan synthase inhibitor
0,046  0,027  AICAR transformylase inhibitor
0,022  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,049  0,030  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,123  0,107  Thrombolytic
0,100  0,085  Adenylate cyclase inhibitor
0,032  0,020  Liver X receptor antagonist
0,072  0,061  Keratolytic
0,013  0,001  Vitamin D-like
0,032  0,022  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,053  0,042  Angiotensin-converting enzyme inhibitor
0,111  0,100  Interleukin 4 antagonist
0,092  0,082  Monophenol monooxygenase inhibitor
0,042  0,032  HIV-1 protease inhibitor
0,018  0,010  Telomerase stimulant
0,122  0,114  Phospholipase A2 inhibitor
0,131  0,126  Sleep disorders treatment
0,078  0,075  T cell inhibitor
0,046  0,044  Protein 50S ribosomal subunit inhibitor
0,143  0,143  Insulin sensitizer

